Live Breaking News & Updates on Tatiana Kisseleva

Stay updated with breaking news from Tatiana kisseleva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Selective, toxin-bearing antibodies could help treat liver fibrosis


 E-Mail
IMAGE: Normal liver tissues (left) do not produce mesothelin, while liver tissue from patients with primary sclerosing cholangitis do (right, darker staining). Mesothelin is a marker of liver fibrosis, and the.
view more 
Credit: UC San Diego Health Sciences
Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.
So we thought.what if we take immunotoxins and try to get them to kill collagen-producing cells in the liver, said team lead Tatiana Kisseleva, MD, PhD, associate professor of surgery at UC San Diego School of Medicine. If these antibodies carrying toxic molecules can find and bind the cells, the cells will eat up the gift and die. ....

San Diego , United States , University Of California San Diego , Kojiro Taura , Takahiro Nishio , Jacopo Baglieri , Tapank Bera , Jamess Hagood , Yukinori Koyama , Tatiana Kisseleva , Keiko Iwaisako , Gen Yamamoto , Lauran Brenner , Ira Pastan , Davida Brenner , Nicholasf Larusso , Xiao Liu , Sarab Rosenthal , Doshisha University , National Cancer Institute , Shangai University Of Medicine , Kyoto University , National Institutes Of Health , Harvard Medical School , Proceedings Of The National Academy Sciences , University Of North Carolina At Chapel Hill ,

Selective immunotoxins may help treat liver fibrosis


Selective immunotoxins may help treat liver fibrosis
Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.
So we thought…what if we take immunotoxins and try to get them to kill collagen-producing cells in the liver. If these antibodies carrying toxic molecules can find and bind the cells, the cells will eat up the gift and die.
Tatiana Kisseleva, MD, PhD, Team Lead, Associate Professor of Surgery, UC San Diego School of Medicine ....

San Diego , United States , University Of California San Diego , Ira Pastan , Tatiana Kisseleva , Emily Henderson , National Cancer Institute , Proceedings Of The National Academy Sciences , National Institutes Of Health , Uc San Diego School Of Medicine , California San Diego School , Diego School , National Academy , National Institutes , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா சான் டியாகோ , எமிலி ஹென்டர்சன் , தேசிய புற்றுநோய் நிறுவனம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , அக் சான் டியாகோ பள்ளி ஆஃப் மருந்து , கலிஃபோர்னியா சான் டியாகோ பள்ளி , டியாகோ பள்ளி , தேசிய கலைக்கழகம் , தேசிய நிறுவனங்கள் ,